GAM
RXII

Gemmer Asset Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Gemmer Asset Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-278
Closed -$1K – 1517
2014
Q3 		$1K Buy
+278
New +$1K ﹤0.01% 1387

Other funds holding RXII

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Gemmer Asset Management's RXII Position: Q4 2014 in Review

Gemmer Asset Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2014, closing a stake of 278 shares — an estimated $1K sold.

Gemmer Asset Management first reported a position in RXII in Q3 2014 and held it in 1 quarter. The position peaked at $1K in Q3 2014. 79 funds tracked by Wall St. Rank hold RXII as of Q4 2014.

  • Gemmer Asset Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2014 after selling out during the quarter.
  • Gemmer Asset Management sold 278 GALENA BIOPHARMA INC COM shares in Q4 2014, an estimated $1K.
  • Gemmer Asset Management first reported a position in GALENA BIOPHARMA INC COM in Q3 2014 and held it in 1 quarter.
  • Gemmer Asset Management's GALENA BIOPHARMA INC COM position peaked at $1K in Q3 2014.
  • 79 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2014.

Based on Gemmer Asset Management's 13F filing for Q4 2014, filed 6 Feb 2015.